Seroconversion issues among out-of-treatment injection drug users

Journal of Psychoactive Drugs

Volumn 30, Issue 3, 1998, Pages 299-305

  Fisher, Dennis G ^a   Fenaughty, Andrea M ^b   Trubatch, Beth ^a  

^a UNIVERSITY OF ALASKA ANCHORAGE   (United States)

^b and Condoms: Ecologies of Risk   (United States)

Author keywords

HIV infection; Injection drug use; Seroconversion

Indexed keywords

AMPHETAMINE DERIVATIVE; COCAINE; DIAMORPHINE; METHADONE; OPIATE DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEACHING; DATA BASE; DEMOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; RACE DIFFERENCE; RISK FACTOR; SEROCONVERSION; SEX DIFFERENCE; SEXUAL BEHAVIOR; UNITED STATES;

EID: 0031695491     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1998.10399705     Document Type: Article

References (45)

1. Anthony, J.C.; Vlahov, D.; Nelson, K.; Cob, S.; Astemborski, J. & Solomon, L. 1991. New evidence on intravenous cocaine use and the risk of infection with Human Immunodeficiency Virus Type I. American Journal of Epidemiology 134 (10): 1175-89.
2. Brooner, R.K.; Greenfield, L.; Schmidt, C.W. & Bigelow, G.E. 1993. Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry 150 (I): 53-8.
3. Chaisson, M.A.; Soneburner, R.L.; Hildebrandt, D.S.; Ewing, W.E.; Telzak, E.E. & Jaffe, H.W. 1991. Heterosexual transmission ofHIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 5: I121-26.
4. Chaisson, M.A.; Soneburner, R.L.; Telzak, E.; Hildebrandt, D.; Schultz, S. & Jaffe, H. 1989. Risk factors for HIV-1 infection in STD clinic patients: Evidence for crack-related heterosexual transmission. International Conference on AIDS 5:117 (T.A.P.112).
5. Chitwood, D.D. & Comerford, M. 1990. Drugs, sex and AIDS risk: Cocaine users versus opiate users. American Behavioral Scientist 33 (4): 465-77.
6. Chitwood, D. D.; Griffin, D. K.; Comerford, M.; Page, J. B.; Trapido, E. J.; Lai, S. & McCoy, C. B. 1995. Risk factors for HIV-1 seroconversion among injection drug users: A case-control study. American Journal of Public Health 85(11): 1538-1542.
7. Chitwood, D.D.; Griffin, D.; McCoy, C.B.; Chitwood, J.S. 1993. Incidence and prevalence of HIV-1 in injection drug users in Miami: A four year panel study. International Conference on AIDS 9 (2): 710 (PO-C15-2959).
8. Des Jarlais, D.C. & Friedman, S.R. 1998. Fifteen years of research on preventing HIV infection among injecting drug users: What we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports 113 (S1): 182-8.
9. Des Jarlais, D.C. & Friedman, S.R. 1987. HIV infection among intravenous drug users: Epidemiology and risk reduction. AIDS I: 67-76.
10. th World AIDS Conference (23168).
11. Dowling-Guyer, S.; Johnson, M.E.; Fisher, D.G.; Needle, R.; Watters, J.; Andersen, M.; Williams, M.; Kotranski, L.; Booth, R.; Rhodes, F.; Weatherby, N.; Estrada, A.L.; Fleming, D.; Deren, S.; & Tortu, S. 1994. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1 (4): 383-92.
12. Ferreira, A.; Arevalo, E.; Fernandes, M E.; Goihman, S. & Hearst, N. 1992. HIV infection among users and new users of injected drugs. International Conference on AIDS 8 (3): 165 (PuC 8072).
13. Fisher, D.G.; Needle, R.; Weatherby, N.; Brown, B.; Booth, R.; & Williams, M. 1993. Reliability of drug user self-report [Abstract]. IXth International Conference on AIDS (PO-C35-3355).
14. Fisher, D.G.; Kuhrt-Hunstiger, T. I.; Orr, S. & Davis, D C. In press. Hepatitis B: An examination of self-report validity in drug users. Psychology of Addictive Behaviors.
15. Friedman, SR.; Jose, B.; Deren, S.; Des Jarlais, DC. & Neaigus, A. 1995. Risk factors for Human Immunodeficiency Virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. American Journal of Epidemiology 142(8):864-74.
16. Greenfield, L.; Bigelow, G.E. & Brooner, R.K. 1992. HIV risk behavior in drug users: Increase blood “booting" during cocaine injection. AIDS Education and Prevention 4 (2): 95-107.
17. Hartel, D.M. & Schoenbaum, E.E. 1998. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Reports 113 (SI): 107-115.
18. Heimer, R. 1998. Personal communication (July).
19. Hochhauser, M. 1989. AIDS prevention in low-incidence areas. Journal of Psychoactive Drugs 21 (4): 401-6.
20. Johnson, ME.; Fisher, D.G. & Reynolds, G.L. In press. Reliability of drug users' self-report of economic variables. Addiction Research.
21. Kahn, H.A. & Sempos, C.T. 1989. Statistical Methods in Epidemiology. New York: Oxford University Press.
22. th World AIDS Conference (13127).
23. Koester, S. 1998. Following the blood: Syringe reuse leads to blood-borne virus transmission among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retroviruses 18 (Suppl. 1): S139-S148.
24. Kritski, A.L.; Wemeck, E.; Carreira, M.; Carvalho, A.C.; Oliveira, J.R.; Longon, A.G. & Janini, M.C. 1992. Tuberculosis and alcoholism among IVDUs infected or not by HIV in Rio de Janeiro Brazil: A prospective study. International Conference on AIDS 8 (2): C358 (PoC 4695).
25. Longshore, D.; Anglin, MD.; Hsieh, S-C. & Annon, K. 1993. Drug-related HIV risk behaviors and cocaine preference among injection drug users in Los Angeles. Journal of Drug Education 23 (3): 25972.
26. Metzger, D.S.; Woody, G.E.; McLellan, AT.; O’Brien, C.P.; Druley, P.; Navaline, H.; DePhilippis, D.; Stolley, P. & Abrutyn, E. 1993. Human Immunodeficiency Virus seroconversion among intravenous drug users in- and out-of-treatment: An lS-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6:1049-56.
27. h World AIDS Conference (23171).
28. National Institute on Drug Abuse. 1991. Risk Behavior Assessment. Rockville, Maryland: National Institute on Drug Abuse.
29. Needle, R.; Fisher, D.G.; Weatherby, N.; Chitwood, D.; Brown, B.; Cesari, H.; Booth, R.; Williams, M L.; Watters, J.; Anderson, M. & Braunstein, M. 1995. The reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors 9 (4): 242-50.
30. Nelson, K.E.; Munoz, A.; Vlahov, D.; Cohn, S. & Solomon, L. 1991. HIV-1 seroconversions in a cohort of i ntravenous drug users. International Conference on AIDS 7 (2): 82 (TH.C.l 02).
31. Nelson, K.E.; Vlahov, D.; Astemborski, J. & Solomon, L. 1995. Incident HIV-1 infections in a cohort of active injection drug users (IDUs) in Baltimore. National Conference on Human Retroviruses and Related Infections (2nd). 344.
32. Nelson, K.E.; Vlahov, D.; Munoz, A.; Cohn, S. & Solomon, L. 1992. Incident HIV-1 infections in a cohort of intravenous drug users (IVDUs). International Conference on AIDS 8 (2): C359 (PoC 4698).
33. Nicolosi, A.; Leite, M.L.C.; Musicco, M.; Molinari, S. & Lazzarin, A. 1992. Parenteral and sexual transmission of Human Immunodeficiency Virus in intravenous drug users: A study of seroconversion. American Journal of Epidemiology 135 (3): 22533.
34. th World AIDS Conference (23172).
35. Paschane, D.M.; Fisher, D.G.; Cagle, H.H. & Fenaughty, A.M. 1998. Gonorrhea among drug users: An Alaskan versus a national sample. American Journal of Drug and Alcohol Abuse 24 (2): 285-97.
36. Schwartz, R.H. 1993. Syringe and needle exchange programs: Part I. Southern Medical Journal 86 (3): 318-22.
37. Siddiqui, N.S.; Brown, L.S.; Meyer, T.J. & Gonzalez, V 1993. Decline in HIV-1 seroprevalence and low seroconversion rate among injection drug users at a methadone maintenance program in New York City. Journal of Psychoactive Drugs 25 (3): 245-50.
38. Sloboda, Z. 1998. What we have learned from research about the prevention of HIV transmission amongdrugabusers. Public Health Reports 113 (SI): 194-204.
39. Strathdee, S.A.; Patrick, DM.; Currie, S.L.; Cornelisse, P.G.A.; Rekart, ML.; Montaner, J.S. G.; Schechter, M.T & O'Shaughnessy, M.V. 1997a. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 11:F59-F65.
40. th Conference on Retroviruses and Opportunistic Infections 134:(378).
41. th World AIDS Conference (583/23198).
42. Tortu, S. 1998. Personal communication (July).
43. Van Ameijden, E.J.C.; van den Hoek, J.A.R.; van Haastrecht, H.J.A. & Coutinho, R.A. 1992. The harm reduction approach and risk factors for Human Immunodeficiency Virus (HIV) seroconversion in injecting drug users, Amsterdam. American Journal of Epidemiology 136:236-43.
44. Weatherby, N.L.; Needle, R.; Cesari, H.; Booth, R.; McCoy, C.; Watters, J.; Williams, M. & Chitwood, D. 1994. Validity of self-reported drug use among injection drug users and crack cocaine users recruitedthrough street outreach. Evaluation and ProgramPlanning 17:347-55.
45. Wiebel, W.W.; Jimenez, A.; Johnson, W.; Ouellet, L.; Jovanovic, B.; Lampinen, T.; Murray, J. & O’Brien, M.U. 1996. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12:282-89.